Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
Van Antwerpen
Pierre
P
Néve
Jean
J
Moreau
Patrick
P
Boudjeltia
Karim Zouaoui
KZ
Vanhaeverbeek
Michel
M
Prévost
Martine
M
Babar
Sajida
S
Legssyer
Ilham
I
Moguilevsky
Nicole
N
Ducobu
Jean
J
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D050197:Atherosclerosis / Q000503:physiopathology / Q000517:prevention & control*; D002712:Chlorides / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects; D009195:Peroxidase / Q000187:drug effects / Q000378:metabolism; D011341:Probucol / Q000008:administration & dosage / Q000494:pharmacology*; D013654:Taurine / Q000378:metabolism
D000924:Anticholesteremic Agents; D002712:Chlorides; D008077:Lipoproteins, LDL; D013654:Taurine; D006861:Hydrogen Peroxide; D009195:Peroxidase; D011341:Probucol